REGIONAL CHEMOINFUSION ARTERIA THORACICA INTERNA IN THE COMBINEITED TREATMENT OF THE BREAST CANCER

REGIONAL CHEMOINFUSION ARTERIA THORACICA INTERNA IN THE COMBINEITED TREATMENT OF THE BREAST CANCER

Direct results nonadjuvant intraarterial chemotherapy are analysed at breast cancer 3 stages at 30 patients under scheme Taxotere 75mg/m2, Doxorubicini 60mg/m2. At the analysis of results after 2 rates intraarterial chemotherapy partial regress at 19 (63,3%) patients, stabilization of...

Full description

Bibliographic Details
Main Authors:	K. R. Umarova, D. T. Arybzhanov, A. N. Ormanov
Format:	Article
Language:	English
Published:	Bashkir State Medical University 2017-01-01
Series:	Креативная хирургия и онкология
Subjects:	регионарная химиотерапия рак молочной железы мастэктомия
Online Access:	https://www.surgonco.ru/jour/article/view/69

Similar Items

INTRA-ATERIAL CHEMOTHERAPY OF THE BREAST CANCER
by: Shamil Kh. Gantsev, et al.
Published: (2017-09-01)

Reconstructive surgery in the complex treatment of breast cancer (10 years of experience)
by: S. A. Khodyrev, et al.
Published: (2021-08-01)

RELAPSES AFTER RADICAL SUBCUTANEOUS/SKIN-SPARING MASTECTOMY WITH SIMULTANEOUS RECONSTRUCTION IN BREAST CANCER
by: A. D. Zikiryakhodzhayev, et al.
Published: (2019-04-01)

Results of single-stage two-stage reconstructive surgeries in young women with breast cancer
by: A. Kh. Ismagilov, et al.
Published: (2022-05-01)

Odnomomentnye mastektomii i laparoskopicheskie ovariektomii v lechenii raka molochnoy zhelezy
by: R A Khvastunov, et al.
Published: (2007-09-01)

Breast Cancer Surgery, History and Current State: a Literature Review
by: E. P. Kashirina, et al.
Published: (2021-10-01)

RECURRENCE OF BREAST CANCER AFTER SUBCUTANEOUS MASTECTOMY WITH SIMULTANEOUS RECONSTRUCTION
by: A. D. Zikiryakhodzhaev, et al.
Published: (2015-01-01)

News on preoperative chemotherapy for breast cancer: according to the proceedings of the 33rd Annual Breast Cancer Symposium (December 8–12, 2010, San-Antonio, USA)
by: S. M. Portnoy
Published: (2014-07-01)

Refinement of drainage-free radical mastectomy as a way to improve direct results of surgical treatment
by: Yu. S. Sidorenko, et al.
Published: (2014-08-01)

Subcutaneous mastectomy with nipple-areolar preservation: new feasibilities of surgical treatment in patients with breast cancer
by: A. A. Volchenko
Published: (2014-08-01)

Combination chemotherapy in the treatment of breast cancer patients with metastatic brain involvement and a poor prognosis
by: D. R. Naskhletashvili, et al.
Published: (2014-07-01)

BIOLOGICAL AND SYNTHETIC MATERIALS IN RECONSTRUCTIVE SURGERY FOR BREAST CANCER TREATMENT (LITERATURE REVIEW)
by: A. D. Zikiryakhodzhaev, et al.
Published: (2018-04-01)

Immediate breast reconstruction using titanised mesh
by: P. V. Krivorotko, et al.
Published: (2020-11-01)

SURGICAL TRETMENT OF EARLY BREAST CANCER: WHAT HAS CHANGED? (EXPERIENCE OF INTERNATIONAL COOPERATION)
by: I. V. Kolyadina, et al.
Published: (2016-02-01)

Current molecular genetic markers of breast cancer
by: N. V. Apanovich, et al.
Published: (2014-07-01)

Impact of various options of neoadjuvant chemotherapy on the hormonal status of patients with breast cancer
by: Yu. S. Sidorenko, et al.
Published: (2014-08-01)

Pectoral nerves block as a component of multimodal analgesia in breast cancer surgery
by: A. S. Buyanov, et al.
Published: (2020-01-01)

SURGICAL RESECTION OF THE PRIMARY TUMOR IN COMBINATION TREATMENT OF PATIENTS WITH STAGE IV BREAST CANCE
by: A. D. Zikiryahodjaev, et al.
Published: (2016-04-01)

SPECIFIC FEATURE OF HORMONAL PROFILE IN PATIENTS WITH PRIMARY AND RECURRENT BREAST CANCER AND THEIR ROLE IN THE EFFICIENCY OF CHEMOTHERAPY
by: M. B. Kozlova, et al.
Published: (2014-09-01)

MECHANISMS OF ACTIVATION OF HEMATOPOIETIC RECOVERY DUE TO FILGASTRIM IN BREAST CANCER PATIENTS RECEIVING CHEMOTHERAPY WITH DOXORUBICIN/DOCETAXEL
by: Т. Yu. Khrichkova, et al.
Published: (2016-02-01)

NSABP B-04 trial 25 years later: lessons for oncologists
by: A. Ya. Kim, et al.
Published: (2019-09-01)

LATE RESULTS OF THE COMBINED MODALITY TREATMENT OF STOMACH CANCER PATIENTS WITH THE APPLICATION OF HI-TECH ENDOVASCULAR METHODS
by: Sh. Kh. Gantsev, et al.
Published: (2017-01-01)

Treatment of thrice-negative breast cancer in a patient with metabolic syndrome
by: G. E. Roitberg, et al.
Published: (2021-03-01)

Early and late postoperative complications of robot-assisted radical subcutaneous mastectomy with endoprosthesis
by: G. E. Kvetenadze, et al.
Published: (2022-01-01)

MODERN POSSIBILITIES OF APPLICATION OF PREPARATION NAVELBINE® IN THE TREATMENT OF METASTATIC BREAST CANCER
by: L. V. Bolotina
Published: (2016-06-01)

Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
by: L. V. Bolotina, et al.
Published: (2014-07-01)

Choice of adjuvant drug therapy on the basis of the molecular classification of breast cancer
by: N. S. Besova
Published: (2014-07-01)

RADIATION THERAPY OF BREAST CANCER WITH ACCOUNT PROGNOSTIC FACTORS
by: K. A. Simonov, et al.
Published: (2016-02-01)

Psychological aspects of patients with breast cancer depending on the presence of visible postoperative defect
by: A. D. Zikiryakhodzhaev, et al.
Published: (2015-06-01)

PREDICTIVE VALUE OF MOLECULAR PARAMETERS IN PATIENTS WITH BASAL-LIKE TRIPL-NEGATIVE BREAST CANCER
by: О. D. Bragina, et al.
Published: (2016-02-01)

Klinicheskaya effektivnost'i bezopasnost' primeneniya otechestvennogo rekombinantnogo granulotsitarnogo koloniestimuliruyushchego faktora Neypomaks® u bol'nykh rakom molochnoy zhelezy, poluchayushchikh khimioterapiyu doksorubitsinom i dotsetakselom
by: L G Zhukova, et al.
Published: (2009-09-01)

Bevatsizumab (Avastin) v kombinatsii s taksanami v 1-y linii lecheniya HER-2-negativnogo metastaticheskogo raka molochnoy zhelezy(Rezul'taty issledovaniya AVADO)
by: L G Zhukova
Published: (2009-03-01)

Sravnitel'noe issledovanie opredeleniya HER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii
by: L E Zavalishina, et al.
Published: (2009-06-01)

Aromazin v ad\"yuvantnoy terapii raka molochnoy zhelezy
by: E V Artamonova
Published: (2009-12-01)

ADJUVANT CHEMOTHERAPY OF PRIMARY OPERABLE LUMINAL B BREAST CANCER WITHOUT OVEREXPRESSION OF HER2/NEU IN POSTMENOPAUSAL WOMEN: YES OR NO?
by: Yu. S. Shatova, et al.
Published: (2017-12-01)

Drug treatment for metastatic breast cancer
by: E. V. Artamonova
Published: (2014-08-01)

The current pattern of reconstructive surgery for breast cancer
by: A. Kh. Ismagilov, et al.
Published: (2015-11-01)

Aberrations of the number of copies (CNA) in the genome of luminal B breast tumor
by: M. K. Ibragimova, et al.
Published: (2020-10-01)

Лечение трижды негативного рака молочный железы у пациентки с метаболическим синдромом.
Published: (2021-03-01)

Breast cancer in young patients. Peculiarities of prognosis and adjuvant hormone therapy (a literature review)
by: D. N. Kravchenko, et al.
Published: (2018-10-01)